SCOT Study Leadership
Daniel E. Furst, MD
Dr. Furst is the first Carl M. Pearson Professor in Rheumatology and a professor of internal medicine at UCLA medical school. He has been on a number of national committees concerned with rheumatic therapeutics, including as a member and fellow in the American College of Rheumatology and the American Society of Clinical Pharmacology and Therapeutics. He has also been a member of the Arthritis Advisory Committee for the FDA. He currently serves as chairman of the Innovative Therapies Meeting of the American College of Rheumatology, Clinical Abstracts Selection chair for the National American College of Rheumatology meeting, and chairman of the Standing Committee on Clinical Trials for the International League Against Rheumatism.
Dr. Furst has served or is serving on the editorial boards of Inpharma, Clinical Drug Investigation, Drugs, The Journal of Clinical Rheumatology, and The Journal of Rheumatology. Additionally, he is an editorial reviewer for professional publications including Arthritis & Rheumatism, The New England Journal of Medicine, Journal of Clinical Investigation, Pharmacotherapy, Annals of the Rheumatic Diseases, and The Journal of Rheumatology.
Dr. Furst has published more than 400 articles and 12 books, including 66 research articles and approximately the same number of reviews or chapters in addition to 2 editions of a book on scleroderma. His areas of research interest include the clinical pharmacology of antirheumatic drugs and biologics and the pathophysiology and treatment of systemic sclerosis.